We'll take you across the border to Belgium, to our agency in Sint-Martens Latem, a picturesque little village renowned for its artistic community, not far from the city of Ghent. The Dotnext and C3 office is located in a Riad-style building, surrounded by nature and...
Based in Saint Contest near Caen, the company founded by Bruno Laÿ relies on a team of top-level R&D engineers specialising in image processing and Artificial Intelligence. ADCIS’ expertise in the field of computer vision is recognised both in France and...
The Evolucare imaging offering and especially its PACS now offers new opportunities to help with diagnosis thanks to two partnerships and artificial intelligence. MILVUE offers a solution designed for triage and offering assistance with diagnosis in emergency...
Launch of a consortium to accelerate AI in medical imaging – Project led by GE Healthcare. The AI DReAM project aims to design and make available to the entire community of developers, doctors in hospitals and VSE-SMEs, an integrated platform that meets the challenges of all stages of development of AI applications in imaging, from data access (images and non-image) to clinical and industrial validation.
Translated with www.DeepL.com/Translator (free version)
A two-fold ambition for Evolucare: international expansion and Artificial Intelligence. Supported by its new partner, Essling Expansion, Evolucare targets a robust growth both internally and externally. The company is relying on Artificial Intelligence, for instance with its new product OphtAI for the detection of diabetic retinopathy, and international expansion to reach its ambitions.
Evolucare will present its new offer OphtAI at the 13th annual meeting of WAEH (The World Association of Eye Hospitals) organized in London (June, 5th-8th) by the prestigious Moorfields Eye Hospital.
We are proud to announce that our new product Evolucare OphtAI is finalist of the « HIT Innovations Trophées 2019 », the innovation contest organized by Paris Healthcare Week
Evolucare & its partner ADCIS, expert SME in applied image analysis for various fields including ophthalmology, chose the International Ophthalmology French Society (125th Edition, 11-14th of May 2019, at Paris Congresses Palace) to seal, on the 12th of May 2019,...
#OphtAI, the new #AI product line of #Evolucare and #ADCIS, gets CE Medical Device Certification. Our Artificial Intelligence, now available for clinical use, identifies diabetic retinopathy from a mere retina fundus image with performances on par with the best retina...
At CES 2019, Evolucare, associated with ADCIS, enters into a global and exclusive license agreement with SATT Ouest Valorisation, a French technology transfer office, and AP-HP Paris hospitals for the exploitation of OphtAI
Evolucare Imaging OphtAI (EIO) was designed to significantly facilitate the organization of DR screening and the follow up of patients through time.
